Inclusion Criteria:  Sign informed consent and voluntarily join the study; Epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer diagnosed by histology or cytology; ≥ 18 years old; The investigator determined that the patient could receive fluzoparib monotherapy or combination therapy; For patients with fertility, effective contraceptive methods should be used during the study period and within 90 days after the last administration of fluzoparib  Exclusion Criteria:  There is evidence that the patient is a pregnant or lactating woman; Participating in any research with intervention measures other than routine clinical practice; 3. The researcher judges other situations that are not suitable for inclusion in the study;